GlassScriptPrepare for your visit
James S Mcdonough
Psychiatry · Longwood, FL · NPI 1063468700
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,794.32
in general payments reported to CMS, 2019-2025 · $1,029 in 2025
The $1,029 reported for 2025 was more than what 81% of Psychiatry providers received nationally (typical 2025 total: $176).
Who reported paying
General payments only, top 6 by amount.
- Janssen Pharmaceuticals, INC $653.10
- Otsuka America Pharmaceutical, INC. $501.48
- Supernus Pharmaceuticals, INC. $370.76
- Neurocrine Biosciences, INC. $359.98
- Lundbeck LLC $341.41
- Abbvie INC. $341.32
Drugs and devices associated with these payments
Rexulti Qelbree Ingrezza Spravato Vraylar Azstarys Trintellix Lybalvi Caplyta Auvelity Cobenfy Loreev Xr
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw James Mcdonough listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/3451/james-s-mcdonough